Literature DB >> 2548186

Constitutive expression of c-myc oncogene confers hormone independence and enhanced growth-factor responsiveness on cells transformed by human papilloma virus type 16.

T Crook1, N Almond, A Murray, M Stanley, L Crawford.   

Abstract

The effect of constitutive expression of the c-myc oncogene on the biological properties of cells transformed or immortalized by human papilloma virus type 16 (HPV16) was studied. Whereas transfection of HPV16 alone into primary baby mouse kidney (BMK) cells failed to generate any immortalized cell lines unless the tumor promoter phorbol 12-myristate 13-acetate was present, cotransfection of HPV16 with a plasmid that constitutively expresses murine c-myc (pSVc-myc-1) generated numerous rapidly growing colonies of cells. Cell lines transformed by HPV16 and pSVc-myc-1 did not require phorbol ester or steroid hormones for growth and were tumorigenic in syngeneic immunocompetent mice. Transfection of pSVc-myc-1 into established cell lines transformed by HPV16 and the v-fos oncogene increased the growth rate and saturation density of these lines severalfold, allowed growth in low-serum medium, and abolished the requirement of these cell lines for glucocorticoids or progestogens. Transfection of the EJ-ras oncogene into these lines did not significantly affect any of these properties.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548186      PMCID: PMC297700          DOI: 10.1073/pnas.86.15.5713

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Tumorigenicity of SEWA murine cells correlates with degree of c-myc amplification.

Authors:  T Martinsson; F Ståhl; P Pollwein; A Wenzel; A Levan; M Schwab; G Levan
Journal:  Oncogene       Date:  1988-10       Impact factor: 9.867

2.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

3.  Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes.

Authors:  H Land; L F Parada; R A Weinberg
Journal:  Nature       Date:  1983 Aug 18-24       Impact factor: 49.962

4.  Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture.

Authors:  H E Ruley
Journal:  Nature       Date:  1983 Aug 18-24       Impact factor: 49.962

5.  DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel; G Urlaub; L Chasin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

6.  Plasmid-encoded hygromycin B resistance: the sequence of hygromycin B phosphotransferase gene and its expression in Escherichia coli and Saccharomyces cerevisiae.

Authors:  L Gritz; J Davies
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

7.  Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers.

Authors:  L Gissmann; L Wolnik; H Ikenberg; U Koldovsky; H G Schnürch; H zur Hausen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

8.  A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions.

Authors:  M Dürst; L Gissmann; H Ikenberg; H zur Hausen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

9.  Fibroblast lines expressing activated c-myc oncogenes are tumorigenic in nude mice and syngeneic animals.

Authors:  E J Keath; P G Caimi; M D Cole
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

10.  Tumorigenicity of fibroblast lines expressing the adenovirus E1a, cellular p53, or normal c-myc genes.

Authors:  A Kelekar; M D Cole
Journal:  Mol Cell Biol       Date:  1986-01       Impact factor: 4.272

View more
  4 in total

1.  C-myc oncogene expression in anal squamous neoplasia.

Authors:  O A Ogunbiyi; J H Scholefield; K Rogers; F Sharp; J H Smith; S V Polacarz
Journal:  J Clin Pathol       Date:  1993-01       Impact factor: 3.411

2.  In vivo Antitumor Effect of an HPV-specific Promoter driving IL-12 Expression in an HPV 16-positive Murine Model of Cervical Cancer.

Authors:  Victor Hugo Bermúdez-Morales; Geny Fierros-Zarate; Celina García-Meléndrez; Juan Manuel Alcocer-Gonzalez; Ausencio Morales-Ortega; Oscar Peralta-Zaragoza; Kirvis Torres-Poveda; Ana Isabel Burguete-García; Eva Hernández-Márquez; Vicente Madrid-Marina
Journal:  J Cancer       Date:  2016-09-27       Impact factor: 4.207

3.  Interferon-Tau has Antiproliferative effects, Represses the Expression of E6 and E7 Oncogenes, Induces Apoptosis in Cell Lines Transformed with HPV16 and Inhibits Tumor Growth In Vivo.

Authors:  Herbey Oswaldo Padilla-Quirarte; Cesar Trejo-Moreno; Geny Fierros-Zarate; Jhoseline Carnalla Castañeda; Marie Palma-Irizarry; Eva Hernández-Márquez; Ana Isabel Burguete-Garcia; Oscar Peralta-Zaragoza; Vicente Madrid-Marina; Kirvis Torres-Poveda; Victor Hugo Bermúdez-Morales
Journal:  J Cancer       Date:  2016-11-05       Impact factor: 4.207

4.  Nuclear proto-oncogene products transactivate the human papillomavirus type 16 promoter.

Authors:  W Nürnberg; M Artuc; G Vorbrueggen; F Kalkbrenner; K Moelling; B M Czarnetzki; D Schadendorf
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.